In vivo production of cyclic peptides
US7105341B2 · kind B2 · utility
11Cited by
2References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 6, 2001 |
| Grant date | Sep 12, 2006 |
| Priority date | — |
| Expiry date | May 21, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The compositions relate to retroviral vectors encoding intein containing polypeptides which, when expressed in an eukaryotic cell, are capable of generating cyclic peptides. The retroviral vectors are used in methods for producing cyclic peptides and for identifying peptides capable of altering cellular phenotypes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.